These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23414481)

  • 1. Health-related resource use and costs in elderly adults with and without mild cognitive impairment.
    Zhu CW; Sano M; Ferris SH; Whitehouse PJ; Patterson MB; Aisen PS
    J Am Geriatr Soc; 2013 Mar; 61(3):396-402. PubMed ID: 23414481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    Robinson RL; Rentz DM; Andrews JS; Zagar A; Kim Y; Bruemmer V; Schwartz RL; Ye W; Fillit HM
    J Alzheimers Dis; 2020; 75(2):437-450. PubMed ID: 32250304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Impact of Progression from Mild Cognitive Impairment to Alzheimer Disease in the United States.
    Frech FH; Li G; Juday T; Ding Y; Mattke S; Khachaturian A; Rosenberg AS; Ndiba-Markey C; Rava A; Batrla R; De Santi S; Hampel H
    J Prev Alzheimers Dis; 2024; 11(4):983-991. PubMed ID: 39044509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of dependence and function on costs of care for Alzheimer's disease and mild cognitive impairment in Ireland.
    Gillespie P; O'Shea E; Cullinan J; Lacey L; Gallagher D; Ni Mhaolain A;
    Int J Geriatr Psychiatry; 2013 Mar; 28(3):256-64. PubMed ID: 23386588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADCS Prevention Instrument Project: pharmacoeconomics: assessing health-related resource use among healthy elderly.
    Sano M; Zhu CW; Whitehouse PJ; Edland S; Jin S; Ernstrom K; Thomas RG; Thal LJ; Ferris SH;
    Alzheimer Dis Assoc Disord; 2006; 20(4 Suppl 3):S191-202. PubMed ID: 17135812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Apathy Evaluation Scale: A Comparison of Subject, Informant, and Clinician Report in Cognitively Normal Elderly and Mild Cognitive Impairment.
    Guercio BJ; Donovan NJ; Munro CE; Aghjayan SL; Wigman SE; Locascio JJ; Amariglio RE; Rentz DM; Johnson KA; Sperling RA; Marshall GA
    J Alzheimers Dis; 2015; 47(2):421-32. PubMed ID: 26401564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.
    Lin PJ; Zhong Y; Fillit HM; Chen E; Neumann PJ
    J Am Geriatr Soc; 2016 Aug; 64(8):1549-57. PubMed ID: 27295430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment.
    Farias ST; Lau K; Harvey D; Denny KG; Barba C; Mefford AN
    J Am Geriatr Soc; 2017 Jun; 65(6):1152-1158. PubMed ID: 28306147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS.
    Reed C; Belger M; Scott Andrews J; Tockhorn-Heidenreich A; Jones RW; Wimo A; Dodel R; Haro JM
    Int Psychogeriatr; 2020 Feb; 32(2):267-277. PubMed ID: 31134870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression from normal cognition to mild cognitive impairment in a diverse clinic-based and community-based elderly cohort.
    Chen Y; Denny KG; Harvey D; Farias ST; Mungas D; DeCarli C; Beckett L
    Alzheimers Dement; 2017 Apr; 13(4):399-405. PubMed ID: 27590706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary evidence for an increased likelihood of a stable trajectory in mild cognitive impairment in individuals with higher motivational abilities.
    Thoma MV; Forstmeier S; Schmid R; Kellner O; Xepapadakos F; Gasser US; Blessing A; Ropohl A; Bieri-Brüning G; Debeer D; Maercker A
    BMC Geriatr; 2018 Aug; 18(1):181. PubMed ID: 30103681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years.
    Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ
    Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and longitudinal changes of informal cost of Alzheimer's disease in the community.
    Zhu CW; Scarmeas N; Torgan R; Albert M; Brandt J; Blacker D; Sano M; Stern Y
    J Am Geriatr Soc; 2006 Oct; 54(10):1596-602. PubMed ID: 17038080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive Predictors of Declining Financial Capacity in Persons with Mild Cognitive Impairment.
    Niccolai LM; Triebel KL; Gerstenecker A; McPherson TO; Cutter GR; Martin RC; Marson DC
    Clin Gerontol; 2017; 40(1):14-23. PubMed ID: 28452629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of Medical Direct Costs of Care among Patients of a Memory Center.
    Dauphinot V; Garnier-Crussard A; Moutet C; Delphin-Combe F; Späth HM; Krolak-Salmon P
    J Prev Alzheimers Dis; 2021; 8(3):351-361. PubMed ID: 34101794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive status is a determinant of health resource utilization among individuals with a history of falls: a 12-month prospective cohort study.
    Davis JC; Dian L; Khan KM; Bryan S; Marra CA; Hsu CL; Jacova P; Chiu BK; Liu-Ambrose T
    Osteoporos Int; 2016 Mar; 27(3):943-951. PubMed ID: 26449355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Amyloid-β, Small-vessel Disease, and Neurodegeneration Biomarker Positivity, and Progression to Mild Cognitive Impairment in Cognitively Normal Individuals.
    Nadkarni NK; Tudorascu D; Campbell E; Snitz BE; Cohen AD; Halligan E; Mathis CA; Aizenstein HJ; Klunk WE
    J Gerontol A Biol Sci Med Sci; 2019 Oct; 74(11):1753-1760. PubMed ID: 30957843
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.